| Active ingredient (INN) | Entecavir |
|---|---|
| Brand names | Viatris, Baraclude |
| ATC level 5 | J05AF10 |
| ATC level 4 | J05AF |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Sandoz Pty Ltd, Sun Pharma ANZ Pty Ltd, Bristol-Myers Squibb Australia Pty Ltd |
| Registrations on file | 27 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Wgr | 0.5mg | — | 🇦🇺 AU | — | Active |
| Wgr | 1.0 mg | — | 🇦🇺 AU | — | Active |
| Sandoz | 0.5 mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| Sandoz | 1 mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| Ran | 0.5mg | — | 🇦🇺 AU | Sun Pharma ANZ Pty Ltd | Active |
| Apo | 1.0 mg | — | 🇦🇺 AU | — | Active |
| BARACLUDE entecavir | 0.5mg | — | 🇦🇺 AU | Bristol-Myers Squibb Australia Pty Ltd | Active |
| BARACLUDE entecavir | 1.0mg | — | 🇦🇺 AU | Bristol-Myers Squibb Australia Pty Ltd | Active |
| Gxp | 0.5 mg | — | 🇦🇺 AU | — | Active |
| HEPBENT entecavir | 0.5 mg | — | 🇦🇺 AU | — | Active |
| Gppl | 1 mg | — | 🇦🇺 AU | — | Active |
| Gppl | 0.5 mg | — | 🇦🇺 AU | — | Active |
| An | 0.5 mg | — | 🇦🇺 AU | — | Active |
| BARENTEC entecavir | 1 mg | — | 🇦🇺 AU | — | Active |
| ENTECABARA entecavir | 0.5 mg | — | 🇦🇺 AU | — | Active |